These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15029262)

  • 1. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
    Eren F; Celikel C; Güllüoğlu B
    Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
    Deveci MS; Deveci G
    Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.
    Nabizadeh Marvast M; Sima HR; Ghaffarzadehgan K; Taghizadeh Kermani A; Norouzi N
    J Gastrointest Cancer; 2011 Mar; 42(1):5-10. PubMed ID: 20922580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].
    Xu F; Liu Q; Han F; Xu E; Lai M; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):24-30. PubMed ID: 27045237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions.
    Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A
    Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A composite adenoendocrine carcinoma of the stomach arising from a neuroendocrine tumor.
    Ronellenfitsch U; Ströbel P; Schwarzbach MH; Staiger WI; Gragert D; Kähler G
    J Gastrointest Surg; 2007 Nov; 11(11):1573-5. PubMed ID: 17436049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.
    Gajra A; Tatum AH; Newman N; Gamble GP; Lichtenstein S; Rooney MT; Graziano SL
    Lung Cancer; 2002 May; 36(2):159-65. PubMed ID: 11955650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.
    Urano N; Fujiwara Y; Doki Y; Tsujie M; Yamamoto H; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
    Gastric Cancer; 2006; 9(1):44-9. PubMed ID: 16557436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of neuroendocrine components in gastric carcinomas.
    Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
    Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
    Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
    Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
    Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
    Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in cervical carcinoma.
    Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
    J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.
    Brouland JP; Manivet P; Brocheriou-Spelle I; Wassef M; Le Bodic MF; Lavergne A; Launay JM
    Endocr Pathol; 2001; 12(1):77-86. PubMed ID: 11478272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 protein as a prognostic factor in patients with gastric cancer.
    Victorzon M; Nordling S; Haglund C; Lundin J; Roberts PJ
    Eur J Cancer; 1996 Feb; 32A(2):215-20. PubMed ID: 8664030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
    Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
    Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.